Company
About us
Our Team
Discoveries
Programs
Publications
Selected
All
ES
Contact Us
Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma
Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma
Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation-mediated hepatocarcinogenesis
‘Sweetening’ pregnancy: galectins at the fetomaternal interface
Mast cells rescue implantation defects caused by c-kit deficiency
Nurse-like cells control the activity of chronic lymphocytic leukemia B cells via galectin-1
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma
TNFRp55 controls regulatory T cell responses in Yersinia-induced reactive arthritis
Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease
A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease
Galectin-1 controls cardiac inflammation and ventricular remodeling during acute myocardial infarction
